Laura Capelli

Papers

Total Citations

H-Index

About

Dr. Laura Capelli is a pioneering researcher in the field of biomedical olfaction and cancer diagnostics, with a primary focus on volatile organic compound (VOC) analysis for non-invasive disease detection. Her most significant contributions center on the application of electronic nose (eNose) technology for prostate cancer risk stratification, as demonstrated in her highly cited 2024 preliminary report. This groundbreaking work explores how urine odor analysis can differentiate between low-risk, slow-growing tumors and aggressive, life-threatening forms of prostate cancer, addressing the critical clinical challenge of over-treatment. With 3 citations already, this study is gaining rapid recognition for its potential to revolutionize patient management by enabling more precise therapeutic interventions. Dr. Capelli’s research bridges analytical chemistry and clinical oncology, offering a non-invasive, cost-effective alternative to traditional biopsy methods. Her work has been instrumental in advancing the field of cancer metabolomics, and she continues to investigate the diagnostic power of VOC signatures across various malignancies. By translating olfactory sensing into actionable clinical tools, Dr. Capelli is helping to shape the future of personalized cancer care.